Sotagliflozin
Overview
Sotagliflozin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3039507).
API suppliers (2)
Suppliers of Sotagliflozin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 1 of 2 suppliers.
1 of 2 holds a GMP certificate on record in the EU or UK registers
- LEE PHARMA LTDIndia1 active DMF GMP on record
- ALP PHARM BEIJING CO LTD1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Sotagliflozin expires 7 Oct 2030 and exclusivity 26 May 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol
- Canonical SMILES
- CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl
- InChIKey
- QKDRXGFQVGOQKS-CRSSMBPESA-N
Do you supply Sotagliflozin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.